Tagrisso-chasing BlossomHill enters Nasdaq queue as biotech IPOs flourish

From the co-founders of Turning Point, BlossomHill Therapeutics filed its IPO paperwork as it tests a macrocyclic small molecule for lung cancer.

Raccontata daendpoints.news